+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

From
From
Infliximab Drug Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Infliximab Drug Market - Global Forecast Report 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
Market Spotlight: Irritable Bowel Syndrome (IBS) (2020) - Product Thumbnail Image

Market Spotlight: Irritable Bowel Syndrome (IBS) (2020)

  • Report
  • March 2020
  • 49 Pages
  • Global
From
From
From
Ulcerative Colitis Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Ulcerative Colitis Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • February 2023
  • 48 Pages
  • Global
From
Dyspepsia (Indigestion) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Dyspepsia (Indigestion) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 420 Pages
  • Global
From
Esophageal Varices - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Esophageal Varices - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • September 2021
  • 102 Pages
  • Global
From
KOL Perspectives: Patient Niches in IBD - Product Thumbnail Image

KOL Perspectives: Patient Niches in IBD

  • Drug Pipelines
  • September 2018
  • 36 Pages
  • Global
From
Sorbitol Market Report and Forecast 2023-2028 - Product Thumbnail Image

Sorbitol Market Report and Forecast 2023-2028

  • Report
  • September 2023
  • 169 Pages
  • Global
From
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more